Long Synthetic Peptides for the Production of Vaccines and Drugs

Science Translational Medicine
22 September 2010 vol 2, issue 50
http://stm.sciencemag.org/content/current

Review
Vaccine and Drug Development
Long Synthetic Peptides for the Production of Vaccines and Drugs: A Technological Platform Coming of Age
Giampietro Corradin, Andrey V. Kajava, and Antonio Verdini
22 September 2010: 50rv3

Abstract
Long synthetic peptides (LSPs) have a variety of important clinical uses as synthetic vaccines and drugs. Techniques for peptide synthesis were revolutionized in the 1960s and 1980s, after which efficient techniques for purification and characterization of the product were developed. These improved techniques allowed the stepwise synthesis of increasingly longer products at a faster rate, greater purity, and lower cost for clinical use. A synthetic peptide approach, coupled with bioinformatics analysis of genomes, can tremendously expand the search for clinically relevant products. In this Review, we discuss efforts to develop a malaria vaccine from LSPs, among other clinically directed work.

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.